Exchange: NASDAQ·Updated 12:36 PM EDT

LKFT Lakefront Biotherapeutics NV - ADR

$28.51
$0.51
(1.76%)
Today
EarningsNov 12
Mkt Cap$1.91B
Vol114,464.00

About LKFT

Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
49

Neutral Sentiment

How do you feel about LKFT?

Advertisement|Remove ads.